The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent cardiac ablation for AFib.
Boston Scientific’s Watchman could be new option for patients post ablation: study Read More »
The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent cardiac ablation for AFib.
Boston Scientific’s Watchman could be new option for patients post ablation: study Read More »
Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices to its shortages list following the recall.
FDA warns providers on Getinge devices tied to 17 serious injuries Read More »
Los penales son uno de los momentos más emocionantes e intensos en el fútbol, donde el destino de un equipo puede decidirse en un solo disparo. En estos instantes cruciales, tanto los porteros como los delanteros enfrentan una presión inmensa que pone a prueba su habil …
La presión del Penalty Shoot Out: la prueba definitiva para porteros y delanteros Read More »
Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space as new devices and heart imaging technology hit the market.
The PFA race is heating up. Here’s where the market stands after J&J’s approval. Read More »
Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead of giving them upfront discounts on 340B drugs.
Eli Lilly follows J&J in suing Biden administration over 340B rebates Read More »
The third temporary extension, which prolongs the pandemic-era flexibilities through the end of 2025, is a relief for telehealth groups who had raised concerns about access to medications.
DEA, HHS issue another extension for telehealth controlled substance prescribing Read More »
Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month milestone.
Cybin’s Small Depression Study Shows 71% Remission Rate Read More »
The deal has secured Novartis the chance to work with Ratio Therapeutics on a novel drug candidate that could fortify the Big Pharma against competition from would-be radiopharmaceutical rivals such as BMS and Lilly.
Novartis Drops Up to $745M to Move Deeper Into Competitive Radiopharma Space Read More »
Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine for about $193.27 for a one-month supply.
Novo’s Wegovy Launched in China at a Fraction of US Price Read More »
